一类周期拟环的结构

本文得到了拟环满足条件ｘｙ＝ｘｙ￣（ｎ（ｘ，ｙ）ｘ或ｘｙ＝ｙｘ￣（ｎ（ｘ，ｙ）ｙ的分解定理。     

二自由度自谐式机器人动力学的研究

本文对引用弹性元件的二自由度谐式机器人的动力学进行了分析,在该模型中引入了负反馈系统。按预期的机构运动规律和系统的稳定性要求,研究了反馈放大系数的合理选择,并对构件单独和同时运动的仿真图线进行了分析。     

可用于累煤层露天矿山的多周期目标规划模型

本文给出了一个可应用于复合煤层露天矿短期生产计划优化的目标规划模型.模型考虑了与煤质、煤产量及开采程序合理性有关的亏损与盈利.该方法利用了带有客观地确定权重系数的目标规划加权法.文后又给出了一个能说明该模型应用于实际采矿问题的例子.     

Manufacturing''s Roel in Innovation Diffusion and Technological Substitution

Successful innovation management depends upon both, the intrinsic attributes of the new product to be marketed and the firm's internal performance like cost management, timely delivery and quality assurance. The impact of these latter aspects is frequently neglected in the design of models for supporting decision making in innovative firms.A model is outlined to study the market response of different manufacturing policies for innovative goods. It allows e.g. the evaluation of an aggressive strategy with large production capacities from the outset, or a more tentative behavior to. avoid the pressures stemming from high fixed cost and the risks of eventually idle capacity.     

Type I phosphatidylinositol kinase makes a novel inositol phospholipid, phosphatidylinositol-3-phosphate

The generation of second messengers from the hydrolysis of phosphatidylinositol-4,5-bisphosphate (PtdInsP2) by phosphoinositidase C has been implicated in the mediation of cellular responses to a variety of growth factors and oncogene products. The first step in the production of PtdInsP2 from phosphatidylinositol (PtdIns) is catalysed by PtdIns kinase. A PtdIns kinase activity has been found to associate specifically with several oncogene products, as well as with the platelet-derived growth factor (PDGF) receptor. We have previously identified two biochemically distinct PtdIns kinases in fibroblasts, and have found that only one of these, designated type I, specifically associates with activated tyrosine kinases. We have now characterized the site on the inositol ring phosphorylated by type I PtdIns kinase, and find that this kinase specifically phosphorylates the D-3 ring position to generate a novel phospholipid, phosphatidylinositol-3-phosphate (PtdIns(3)P). In contrast, the main PtdIns kinase in fibroblasts, designated type II, specifically phosphorylates the D-4 position to produce phosphatidylinositol-4-phosphate (PtdIns(4)P), previously considered to be the only form of PtdInsP. We have also tentatively identified PtdIns(3)P as a minor component of total PtdInsP in intact fibroblasts. We propose that type I PtdIns kinase is responsible for the generation of PtdIns(3)P in intact cells, and that this novel phosphoinositide could be important in the transduction of mitogenic and oncogenic signals.     

Multiple liquid crystal phases of DNA at high concentrations

DNA packaging in vivo is very tight, with volume concentrations approaching 70% w/v in sperm heads, virus capsids and bacterial nucleoids. The packaging mechanisms adopted may be related to the natural tendency of semi-rigid polymers to form liquid crystalline phases in concentrated solutions. We find that DNA forms at least three distinct liquid crystalline phases at concentrations comparable to those in vivo, with phase transitions occurring over relatively narrow ranges of DNA concentration. A weakly birefringent, dynamic, 'precholesteric' mesophase with microscopic textures intermediate between those of a nematic and a true cholesteric phase forms at the lowest concentrations required for phase separation. At slightly higher DNA concentrations, a second mesophase forms which is a strongly birefringent, well-ordered cholesteric phase with a concentration-dependent pitch varying from 2 to 10 micron. At the highest DNA concentrations, a phase forms which is two-dimensionally ordered and resembles smectic phases of thermotropic liquid crystals observed with small molecules.     

Brain-derived neurotrophic factor prevents neuronal death in vivo

Developing vertebrate neurons are thought to depend for their survival on specific neurotrophic proteins present in their target fields. The limited availability of these proteins does not allow the survival of all neurons initially innervating a target, resulting in the widely observed phenomenon of naturally occurring neuronal death. Although a variety of proteins have been reported to promote the survival of neurons in tissue culture, the demonstration that these proteins increase neuronal numbers and/or decrease neuronal death in vivo has only been possible with nerve growth factor (NGF). The generalization of the concept that neurotrophic proteins regulate neuronal survival during normal development critically depends on the demonstration that the survival of neurons in vivo can be increased by the administration of a neurotrophic protein different from NGF. We report here that this is the case with brain-derived neurotrophic factor, a protein of extremely low abundance purified from the central nervous system.